Member Info for LeBadinho

i don't think that there will be one. It needs the right price target and to be honest I don't think that Geremy Thomas will sell that company for less than 100mio pounds.

If that will happen the SP will go up automatically ;D

what do you mean by that? can you explain it? because there is no big strategic change at all since Geremy took over.

Sativa bougth a CBD company (Stillcanna) during a time where it was not clear how the British govermental instituations will come up with CBD legalization. During that time they secured the whole business by diversification.

They added revenues and cash by doing some adjustments on their whole company strategy. So nothing has changed dramatically. CBD business is still there and will grow if the market regualtions are clear. And the health care business will help to get revenues in the deposit during that time.

well, I'm a german shareholder and already set some additional buys on the german side. But to be honest, you should have a look on the SP for the next week. If it decreases more, I will add some more.

CSE de-listing needed to be done. WOuld have been better do it with the takeover in 2020/beginning of 2021 but it was necessary to open news doors to institutional investors in the UK/Europe.

to add something more on that:

I think most of the canadian guys didn't get the point that they will still be able to trade their shares. Maybe it's some kind of bad game that canadian brokers telling their clients that they will not be able anymore to trade after de-listing. but that is not true at all.

so hopefully an interview and some detailed information about future trading possibilities for canadian shareholders will cover it.

He guys,

what is wrong to makes such a huge step for the company by getting delisted in Canada where is no company business done!! Most of German investors don'T want to invest in Canadian small caps anymore so european institutional investors do.

Okay, it's pretty ugly wants currently going on in Canada but to be honest it was a necessary step for the future success of the company in Europe. Hopefully there will be an interview wih Marc or Geremy to explain it in more detail and make the current shareholders more comfortable with that major decision.

And I totally agree with alarno. Even if the Clinic network rollout is lacking a bit behind and the FSA novel food list currently not showd a big impact the revenue and cash is there to bring the company in the right position for the future starting right now.

I started my investment last year. Primarily on the basis of the clinic approach.

I am therefore not in the red like many here.

I have shared many of the points you mentioned with GDBY. Different market (LSE not AQSE), sharing news via Sharecast so that more shareholders are informed. Especially in the UK.

I also pointed out several ways to do PR. I hope that it will slowly bear fruit.

If the Q2 figures show that the blood test business is working, then others will join in.

i don't know more than you guys. But they always do their operational business in the background. And the time is primed to get some cheap CBD companies currently.

So why not growing by M&A in that part?

I'm also asking since month regarding new selling possibilities for their CBD products (Amazon UK,...).

Currently, I would like to see a big cooperation with a pharmacy group for the blood testing stuff.

@MBPUK: what have been your expectations?

there is a lot going on in the background. ;D
Currently its just a waiting game.

Interview link
https://vimeo.com/714350783

I think it was a great news release yesterday. Today there was release a interview with Marc Howells on directors talk interviews.

I think currently on websites are 214 clinics.
nearly 135 are currently diling with blood testing.

Great numbers.

I think there will be more press releases before Q&A. Otherwise they will not be able to handle all of our questions :D

Looks like that it will take place right after the Q1 fins announcement. When ver that will be. I guess the Q1 fins will be out in during the week starting 23rd of May. *fingers crossed*

thanks for sharing!!

There is a normal user/shareholder who is doing a lot of fins reviews. He has a lot of experience with a financial background.

Great results for GDBY

https://wolfofoakville.com/fins-reviews/f/goodbody-health-gdbyc-4-5-stars

Really great numbers. You guys also need to have a look into the new Arden report. This makes it clear again

He guys,

IR from GDBY asking if there is the need of a Q&A session with Chairman, CEO and CFO of the company.

answered your question in the other thread. :D

You're absolutely right. 101 :D I'm updating my google map all the time if there is something new. Feel free to have a look at it.

https://www.google.com/maps/d/edit?hl=de&mid=1tw7vKhcoYWBTXrjmg_fOEO7hz_T6xvce&ll=53.345967968074405%2C-5.5057749906250075&z=6

well, I think she had a lot of stress last week regarding the audited financial 2021.
I had contact last week several times with here. She answered with delays but she answered.

If you want i can maybe help you out. I think a shareholder Q6A session with Marc and/or Geremy would be great toanswer as many quesions as possible.

https://www.thegrocer.co.uk/buying-and-supplying/david-beckham-backed-cbd-brand-pulls-ingestibles-range/666861.article